Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03384108 · ClinicalTrials.gov registry record · NA

In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells

A NA study of Healthy, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03384108: Recruiting NA study of Healthy, sponsored by Mayo Clinic.

NCT03384108 is a NA study of Healthy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03384108, a NA study of Healthy, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This pilot study will first establish the feasibility of an in vivo methodology of assessing the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells from healthy subjects while comparing it to an ex vivo approach

Conditions Studied

Interventions

  • OTHER 5-13C-Glutamine
  • OTHER Bone marrow aspiration

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-09-01
Est. Completion 2028-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03384108

The ClinicalTrials.gov registry entry for NCT03384108 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which 5-13C-Glutamine is the first listed.

NCT03384108 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03384108 about?

NCT03384108 is a clinical study titled "In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells". This pilot study will first establish the feasibility of an in vivo methodology of assessing the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells from healthy subjects while comparing it to an ex vivo approach

What is the current status of trial NCT03384108?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2017-09-01. Estimated completion is 2028-01.

What conditions does trial NCT03384108 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03384108?

The interventions under investigation include: 5-13C-Glutamine (OTHER), Bone marrow aspiration (OTHER).

Who is sponsoring clinical trial NCT03384108?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03384108 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.